Ricart W, López J, Mozas J, Pericot A, Sancho M A, González N, Balsells M, Luna R, Cortázar A, Navarro P, Ramírez O, Flández B, Pallardo L F, Hernández-Mijas A, Ampudia J, Fernández-Real J M, Corcoy R
Unit of Diabetes, Endocrinology and Nutrition, University Hospital Doctor Josep Trueta, Avgda. de frança s.n., 17007, Girona, Spain.
Diabetologia. 2005 Sep;48(9):1736-42. doi: 10.1007/s00125-005-1877-1. Epub 2005 Jul 29.
AIMS/HYPOTHESIS: We evaluated diabetes-related pregnancy outcomes in a cohort of Spanish women in relation to their glucose tolerance status, prepregnancy BMI and other predictive variables.
The present paper is part of a prospective study to evaluate the impact of American Diabetes Association (2000) criteria in the Spanish population. A total of 9,270 pregnant women were studied and categorised as follows according to prepregnancy BMI quartiles and glucose tolerance status: (1) negative screenees; (2) false-positive screenees; (3) gestational diabetes mellitus (GDM) according to American Diabetes Association criteria only; and (4) GDM according to National Diabetes Data Group criteria (NDDG). We evaluated fetal macrosomia, Caesarean section and seven secondary outcomes as diabetes-related pregnancy outcomes. The population-attributable and population-prevented fractions of predictor variables were calculated after binary logistic regression analysis with multiple predictors.
Both prepregnancy BMI and abnormal glucose tolerance categories were independent predictors of pregnancy outcomes. The upper quartile of BMI accounted for 23% of macrosomia, 9.4% of Caesarean section, 50% of pregnancy-induced hypertension and 17.6% of large-for-gestational-age newborns. In contrast, NDDG GDM accounted for 3.8% of macrosomia, 9.1% of pregnancy-induced hypertension and 3.4% of preterm births.
CONCLUSIONS/INTERPRETATION: In terms of population impact, prepregnancy maternal BMI exhibits a much stronger influence than abnormal blood glucose tolerance on macrosomia, Caesarean section, pregnancy-induced hypertension and large-for-gestational-age newborns.
目的/假设:我们评估了一组西班牙女性的糖尿病相关妊娠结局,这些结局与她们的糖耐量状况、孕前体重指数(BMI)及其他预测变量有关。
本文是一项前瞻性研究的一部分,该研究旨在评估美国糖尿病协会(2000年)标准对西班牙人群的影响。共研究了9270名孕妇,并根据孕前BMI四分位数和糖耐量状况将其分类如下:(1)筛查阴性者;(2)假阳性筛查者;(3)仅根据美国糖尿病协会标准诊断的妊娠期糖尿病(GDM);(4)根据国家糖尿病数据组标准(NDDG)诊断的GDM。我们评估了巨大儿、剖宫产及七种作为糖尿病相关妊娠结局的次要结局。在对多个预测因素进行二元逻辑回归分析后,计算了预测变量的人群归因分数和人群预防分数。
孕前BMI和糖耐量异常类别均为妊娠结局的独立预测因素。BMI的上四分位数占巨大儿的23%、剖宫产的9.4%、妊娠高血压的50%以及大于胎龄儿的17.6%。相比之下,NDDG GDM占巨大儿的3.8%、妊娠高血压的9.1%以及早产的3.4%。
结论/解读:就人群影响而言,孕前母亲BMI对巨大儿、剖宫产、妊娠高血压和大于胎龄儿的影响远强于血糖耐量异常。